IP Library Granted Patent US 9,101,555
Granted Patent B1
US 9,101,555 · App. 14/682,552 · Granted Aug 11, 2015

Magnolia extract containing compositions

Inventors: Jim Faller (Williamsville, NY); David Gan (Southlake, TX); Michelle Hines (Hickory Creek, TX); Lisa Mangos (Katy, TX)
Assignee: Mary Kay Inc.
A61K8/97A61K8/347A61Q19/00A61Q19/007A61Q19/008A61Q19/08A61K2800/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,555
App. No.
14/682,552
Granted
Aug 11, 2015
Kind
B1
Abstract

Disclosed is a composition and method for its use that includes Magnolia bark extract, vitis vinifera extract, tocopherol or tocopherol acetate, and hydrogenated lecithin, lecithin, or dextrin.

Claims (26)

1. A topical skin composition comprising:

(i) Magnolia officinalis bark extract;

(ii) Vitis vinifera seed extract;

(iii) tocopherol or tocopherol acetate;

(iv) lecithin;

(v) water;

(vi) glycerin; and

(vii) phenoxyethanol.

2. The topical skin composition of claim 1 , wherein the magnolia officinalis bark extract comprises honokiol.

3. The topical skin composition of claim 1 , wherein the composition further comprises:

(viii) dimethicone;

(ix) sodium hyaluronate; and

(x) butylene glycol.

4. The topical skin composition of claim 3 , wherein the composition further comprises:

(xi) polysorbate 20; and

(xii) xanthan gum.

5. The topical skin composition of claim 3 , wherein the composition further comprises:

(xi) caprylic/capric triglyceride.

6. The topical skin composition of claim 5 , wherein the composition further comprises:

(xii) xanthan gum.

7. The topical skin composition of claim 1 , wherein the composition further comprises:

(viii) polysorbate 20; and

(ix) caprylic/capric triglyceride.

8. The topical skin composition of claim 1 , wherein the lecithin is hydrogenated lecithin.

9. A method of treating skin comprising topically applying the composition of claim 1 to skin.

10. The method of claim 9 , wherein the composition is applied to inflamed skin.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 069414/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2022
From: BELAJ INNOVATIONS, LLC
To: MARY KAY INC.
Reel/Frame 062144/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2020
From: ALLUSTRA TECHNOLOGIES LLC
To: BELAJ INNOVATIONS LLC
Reel/Frame 054186/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2020
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 054112/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2015
From: FALLER, JIM; GAN, DAVID; HINES, MICHELLE; MANGOS, LISA
To: MAY KAY INC.
Reel/Frame 035371/0090 →
Continuity (5)
Continuation 14289262 · May 28, 2014
Continuation 13297755 · Nov 16, 2011
Continuation 12706557 · Feb 16, 2010
Continuation 12048953 · Mar 14, 2008
Provisional Application 60912793 · Apr 19, 2007